BSEInsider Trading / SAST17h ago · 28 Sept 2026, 12:17 pm
Closure of trading window under Insider Trading Code
Aptus Pharma Ltd · 544529
✦ AI Summary
Aptus Pharma Ltd has announced the closure of its trading window under the Insider Trading Code, effective from October 1, 2026, until the completion of 48 hours after the declaration of its half-yearly financial results for September 30, 2026.
Analysis Scores
Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Aptus Pharma Ltd - 544529 - Closure of Trading Window
Attachments (1)
📄pdf
Download →
813d49d7-6e92-46b9-8a82-6c209d11a30f.pdf
View document text
APTUS PHARMA LIMITED
Date: 28.09.2026
The BSE Ltd
Phiroze Jeejeebhoy Tower,
Dalal Street,
Mumbai – 400001
SECURITY CODE: 544529
SCRIPT SYMBOL: APPL
Dear Sir,
Sub: Closure of Trading Window under Insider Trading Code
This is to inform you that pursuant to Company’s Code of Conduct for Prohibition of Insider
Trading, the “Trading Window” for dealing in securities of the Company shall remain closed
from October 01, 2026 until completion of 48 hours after the declaration of the Financial
Results of the Company for the half year ended September 30, 2026.
This is for your kind information and necessary records.
Yours faithfully,
For Aptus Pharma Limited
Tejash Hathi
Managing Director
DIN: 03151221
Regd. Address: Ashutosh Buildcon, Opp. Slok – 2, Nr. Harikrupa Logistic Park, Aslali, Daskroi,
Ahmedabad, Gujarat – 382427, India
Contact: 76004 27827, E-mail: aptuspharma@rediffmail.com, Website: www.aptus-pharma.com
CIN: U24230GJ2010PLC061957, GSTIN: 24AAICA7890D1ZM